Baker Hughes Co

**Signal Note: Eventide Initiates BKR Position** This position is notable primarily for Eventide's investment mandate rather than biotech-specific catalysts—Baker Hughes is an industrial equipment/services company with minimal direct pharma exposure. The $16M position suggests Eventide may be positioning for energy sector dynamics or viewing BKR through an ESG lens aligned with their values-based strategy, but this represents a notable pivot away from their traditional biotech focus and warrants monitoring for strategic rationale clarification.